High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases - Report - MDSpire

High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases

  • By

  • Marit A. Martiniussen

  • Marie B. Bergan

  • Merete U. Kristiansen

  • Nataliia Moshina

  • Anne Sofie F. Larsen

  • Marthe Larsen

  • Fredrik A. Dahl

  • Solveig Hofvind

  • May 6, 2026

  • 0 min

Share

Clinical Report: Assessment of Breast Cancer Risk Using AI on Mammograms

Overview

This study evaluates the effectiveness of artificial intelligence (AI) in assessing breast cancer risk through screening mammograms. It highlights the differences in mammographic features associated with high AI risk scores in women with and without screen-detected breast cancer, aiming to enhance interpretive accuracy and workflow efficiency in mammography.

Background

Breast cancer remains the most prevalent cancer among women globally, necessitating effective screening strategies for early detection. Mammographic screening, while beneficial, is associated with challenges such as overdiagnosis and false positives, which can lead to psychological distress and reduced screening adherence. The integration of AI in mammography has the potential to improve diagnostic accuracy and reduce unnecessary recalls, making it a critical area of research.

Data Highlights

Replace '

No numerical data available in the provided source material.

' with a summary of key findings, if applicable.

Key Findings

Revise to include specific data points or examples from the study to support each finding.

Clinical Implications

Healthcare professionals should consider the integration of AI tools in mammography to enhance diagnostic accuracy and reduce unnecessary recalls. Understanding the specific mammographic features that influence AI risk scores can aid radiologists in making more informed decisions during screenings.

Conclusion

The study underscores the importance of AI in refining breast cancer screening processes. By elucidating the characteristics of mammographic features linked to AI risk scores, it aims to improve both the accuracy of diagnoses and the efficiency of screening programs.

Related Resources & Content

  1. European Radiology, 2024 -- The Role of Artificial Intelligence as a Supplementary Reader in Breast Cancer Screening Diagnostics
  2. European Radiology, 2026 -- From pixels to pathology: how artificial intelligence mammographic risk scores capture tumor biology through imaging
  3. The ASCO Post, 2025 -- Large AI Breast Cancer Screening Trial Increases Detection Rate by 20%
  4. European Radiology, 2025 -- Analysis of a CE-certified AI system based on 1,017,208 mammography screening assessments
  5. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
  6. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial - ScienceDirect
  7. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
  8. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial - ScienceDirect
  9. https://academic.oup.com/jnci/article/118/3/392/8416736

Original Source(s)

Related Content